Surprisingly, polymorphisms in UGT2B7 have been significantly associated with morphine-induced adverse effects in a study on Japanese cancer patients under oral controlled-release morphine: the frequency of nausea was significantly associated with the UGT2B7*2 (p = 0.023), which appears to have a protective effect [54]. The gene discussed is UGT2B7; the disease is cancer.